DEF 14A: Simulations Plus Sets Date for 2025 Annual Shareholder Meeting, Outlines Key Proposals

Simulations Plus will hold its Annual Meeting of Shareholders on February 13, 2025, to elect directors, ratify the accounting firm, and vote on executive compensation.

Summary

• Simulations Plus, Inc. will hold its Annual Meeting of Shareholders on February 13, 2025, at 2:00 p.m. Pacific Time, in a virtual format.
• Shareholders of record as of December 17, 2024, are entitled to vote on the election of five directors, the ratification of Rose, Snyder & Jacobs LLP as the independent registered public accounting firm for the fiscal year ending August 31, 2025, and an advisory vote on executive compensation.
• The Board of Directors recommends voting FOR all director nominees and FOR the ratification of the accounting firm and approval of executive compensation.
• Proxy materials are primarily available electronically, with a Notice of Internet Availability mailed to shareholders on or about December 23, 2024.
• The company's common stock is its only class of voting securities issued and outstanding, with 20,085,492 shares issued and outstanding as of the record date.

Sentiment

Score: 7

Explanation: The document is a standard proxy statement, presenting information in a neutral tone. The Board's recommendations suggest a positive outlook, but the document primarily serves to inform shareholders.

Positives

• The Board recommends voting FOR all proposals, indicating confidence in the company's direction.
• The company is committed to Environmental, Social, and Governance (ESG) practices, fostering a commitment to sustainability and ethical standards within our organization.
• The company was recognized by Comparably as Best Company for Diversity, Best Company for Women, Best Company Culture, and a Best Company Compensation awards winner, as determined based on direct feedback from our employees.

Negatives

• The overall compensation of the Company's non-executive directors was temporarily reduced by 10% to align with other annual company expense reduction initiatives and the $15,000 Lead Independent Director cash stipend was removed for fiscal year 2025 (concurrent with the elimination of the Lead Independent Director position).

Risks

• The document does not explicitly detail any specific risks, but general business and economic risks always exist.
• Failure to achieve the performance metrics tied to executive bonuses could impact executive motivation and retention.

Future Outlook

The Board intends to consider the outcome of the advisory vote on executive compensation when making future decisions.

Management Comments

• The Board of Directors has carefully reviewed and considered the foregoing proposals and has concluded that each proposal is in the best interests of the Company and its shareholders.
• The Board recommends that you vote FOR each of the director nominees included in the accompanying Proxy Statement and FOR each of the other foregoing proposals.

Industry Context

The document does not provide specific details on how this announcement relates to broader industry trends or competitors, but the company's focus on pharmaceutical and biotech industries is mentioned.

Comparison to Industry Standards

• The document mentions benchmarking executive compensation against a comparable peer group, but does not list specific companies.
• The company employs performance metrics that compare our cumulative shareholder return on our common stock, assuming reinvestment of dividends to the extent there are any distributed during the period, relative to the S&P Small Cap 600 and the S&P 600 Health Care Technology Industry Index.

Management Changes

Corporate Governance

Stakeholder Impact

• Shareholders are asked to vote on key proposals that will impact the company's governance and direction.
• Employees are indirectly impacted by decisions regarding executive compensation and company performance.

Next Steps

• Shareholders should review the proxy materials and vote their shares by the specified deadline.
• The company will announce preliminary voting results at the Annual Meeting and report final results in a Form 8-K.

Key Dates

Keywords

shareholders, proxy, directors, compensation, voting, meeting, Simulations Plus, governance, audit